Sichenzia Ross Ference LLP Represents Murphy Canyon Acquisition Corp. in Business Combination with Conduit Pharmaceuticals Limited
Press Release – New York, NY – September 22, 2023 – Sichenzia Ross Ference LLP announced today that it represented Murphy Canyon Acquisition Corp., a special purpose acquisition company, in its business combination transaction with Conduit Pharmaceuticals Limited (“Conduit”). Conduit is a multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development. Securities of the combined company are expected to commence trading on Nasdaq on September 25th, 2023.
The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio, Avital Perlman, Arthur Marcus, counsel Sharon Carroll and associates Jesse Blue and Chance Moore.